Crossmark

β-caryophyllene, a CB2-selective phytocannabinoid, differentially modulates attention and inhibitory control in low- and high-performing young and aged mice

Crossref DOI link: https://doi.org/10.1007/s00213-026-07093-w

Published Online: 2026-05-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

M.N., Williams

N.T., Patel

E.J., Fleischel

M.E., Wimmer

S.J., Ward

V., Parikh
Funding

Funding for this research was provided by:

National Center for Complementary and Integrative Health (3R01 AT010778-02S1)
License Information

Text and Data Mining valid from 2026-05-18

Version of Record valid from 2026-05-18
More Information

Article History

Received: 30 September 2025

Accepted: 12 May 2026

First Online: 18 May 2026

Declarations

:

: All animal studies were approved by Temple University Institutional Animal Use and Care Committee (protocol # 5084) and conducted in accordance with the guidelines from the National Institute of Health.

: Not applicable.

: All authors consented to publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below